Konrad H Bleicher

USPTO Granted Patents = 46 (Patent Applications = 13)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 19 (Patent Applications = 20)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 111(Granted Patents)

Location History:

Freiburg, DE (2002 - 2018)
Freiburg i. Br., DE (2018)
Basel, CH (2018 - 2023)

Company Filing History:

43 out of 4,942

Hoffmann-la Roche Inc.

Roche Innovation Center Copenhagen A/s

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11819532 - Peptide macrocycles against (2023-11-21),

2. 11597926 - Thiophosphoramidites (2023-03-07),

3. 11591362 - Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides (2023-02-28),

4. 11505573 - Peptide macrocycles against (2022-11-22),

5. 11390641 - 5'S-LNA nucleotides and oligonucleotides (2022-07-19),

6. 11098080 - Peptide macrocycles against Acinetobacter baumannii (2021-08-24),

7. 11091514 - Peptide macrocycles and use thereof in the treatment of bacterial infections (2021-08-17),

8. 11066443 - Anti-bacterial peptide macrocycles and use thereof (2021-07-20),

9. 10137170 - Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides (2018-11-27),

10. 10030047 - Peptide macrocycles against acinetobacter baumannii (2018-07-24),

11. 9957298 - Peptides as oxytocin agonists (2018-05-01),

12. 9868772 - Analogs of glucagon exhibiting GIP receptor activity (2018-01-16),

13. 9868766 - Peptides as oxytocin agonists (2018-01-16),

14. 8703768 - Nitrogen containing heteroaryl compounds (2014-04-22),

15. 8470820 - Nitrogen-containing heteroaryl derivatives (2013-06-25),

Title: Innovator Spotlight: Konrad H. Bleicher

Introduction: Konrad H. Bleicher is a notable inventor based in Freiburg i. Br., Germany, recognized for his significant contributions to the field of pharmaceuticals and biochemistry. With an impressive portfolio of 46 patents, Bleicher continues to influence the scientific community through his innovative research and developments.

Latest Patents: Among his latest patents, Bleicher has focused on groundbreaking compounds, including peptide macrocycles designed to address various biological challenges. One of his notable inventions involves thiophosphoramidites, specifically a compound of formula (II) or (IIb), where specific variables such as X, Y, R, and Nu are defined within the patent's description and claims. This particular compound has potential applications in the manufacture of oligonucleotides, demonstrating his capacity to bridge chemistry and biotechnology.

Career Highlights: Throughout his career, Konrad H. Bleicher has made significant strides while working with prominent institutions. He has contributed his expertise at Hoffman-La Roche Inc. and the Indiana University Research and Technology Corporation, where his work has helped pave the way for advancements in drug discovery and molecular biology.

Collaborations: Collaborating with esteemed colleagues like Bernd Kuhn and Gregory Martin Benson has further enhanced Bleicher's research contributions. These partnerships in academia and industry exemplify his dedication to fostering innovation through teamwork and shared knowledge.

Conclusion: Konrad H. Bleicher stands out as a prolific inventor whose work has implications for the future of biotechnology and pharmaceuticals. His 46 patents reflect his commitment to innovation and his ability to solve complex scientific problems, making him a key figure in his field.

This text is generated by artificial intelligence and may not be accurate.